TMCI:NASDAQ
Treace Medical Concepts, Inc
US$ 4,42
0,00%
(0,00) 1D
US$ 4,43
arrow_upward
+0,23% (+0,0100)todayVóór openingstijd
Gesloten: 16 nov, 16:00:00 GMT-5 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor TMCI genereren…
Beursw.
289,77 mln.
Gem. vol.
305,25K
Volume
228,00
52 wk hoog
US$ 5,43
52 wk laag
US$ 1,17
WPA
US$ -0,86
Bèta
1,59
Uitstaande aandelen
65,56 mln.
Aantal medewerkers
450
Beursw.
289,77 mln.
Gem. vol.
305,25K
Volume
228,00
52 wk hoog
US$ 5,43
52 wk laag
US$ 1,17
WPA
US$ -0,86
Bèta
1,59
Uitstaande aandelen
65,56 mln.
Aantal medewerkers
450
Nieuwsartikelen
Van webbronnen en nieuwspartners
ChartMill
·
31 minuten geleden
S&P 500 Premarket Movers on Nov. 17: Gainers and Losers
FOREX.com
·
56 minuten geleden
S&P 500 forecast: Why US stocks have largely defied gravity and what could trigger a correction
Investor's Business Daily
·
1 uur geleden
Analysts Expect 4 S&P 500 Stocks To Outgrow Nvidia Next Year
Quartz
·
1 uur geleden
The Dow fell more than 700 points on Monday and the S&P 500 lost 1.9%
Profiel
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Over Treace Medical Concepts, Inc